Table 3.
Variables | Comparison for OR | Univariate analysis (n = 65) |
Multivariate analysis (n = 65) |
||||||
---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | p value | OR | 95% CI | p value | ||||
EPIC1 | High versus low expression | 0.259 | 0.078 | 0.864 | 0.028 | 0.225 | 0.056 | 0.909 | 0.036 |
Age | ⩾50 versus <50 years | 0.688 | 0.216 | 2.189 | 0.526 | 0.257 | 0.051 | 1.292 | 0.099 |
T stage | T3–T4 versus T2 | 0.244 | 0.066 | 0.901 | 0.034 | 0.238 | 0.047 | 1.215 | 0.084 |
N stage | N1–N3 versus N0 | 1.556 | 0.167 | 14.455 | 0.698 | 1.109 | 0.093 | 13.256 | 0.935 |
ER status | Positive versus negative | 0.259 | 0.078 | 0.864 | 0.028 | 0.177 | 0.029 | 1.066 | 0.059 |
PR status | Positive versus negative | 0.490 | 0.150 | 1.596 | 0.236 | 1.161 | 0.213 | 6.326 | 0.863 |
Ki67 index | ⩾20% versus <20% | 1.909 | 0.211 | 17.243 | 0.565 | 1.563 | 0.097 | 25.113 | 0.753 |
Bold numerals indicate statistical significance.
CI, confidence interval; ER, estrogen receptor; N stage, nodal stage; OR, odds ratio; PR, progesterone receptor; T stage, tumor stage.